Hulot JS - Search Results

1

Beta-blocker benefit according to severity of heart failure.

Bouzamondo A, Hulot JS, Sanchez P, Lechat P. Bouzamondo A, et al. Among authors: hulot js. Eur J Heart Fail. 2003 Jun;5(3):281-9. doi: 10.1016/s1388-9842(03)00042-4. Eur J Heart Fail. 2003. PMID: 12798825 Free article. Review.

2

Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.

Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, Pochmalicki G, Dargie H. Lechat P, et al. Among authors: hulot js. Circulation. 2001 Mar 13;103(10):1428-33. doi: 10.1161/01.cir.103.10.1428. Circulation. 2001. PMID: 11245648 Clinical Trial.

3

Beta-blocker treatment in heart failure.

Bouzamondo A, Hulot JS, Sanchez P, Cucherat M, Lechat P. Bouzamondo A, et al. Among authors: hulot js. Fundam Clin Pharmacol. 2001 Apr;15(2):95-109. doi: 10.1046/j.1472-8206.2001.00019.x. Fundam Clin Pharmacol. 2001. PMID: 11468019 Review.

4

Planning and monitoring of placebo-controlled survival trials: comparison of the triangular test with usual interim analyses methods.

Hulot JS, Cucherat M, Charlesworth A, Van Veldhuisen DJ, Corvol JC, Mallet A, Boissel JP, Hampton J, Lechat P. Hulot JS, et al. Br J Clin Pharmacol. 2003 Mar;55(3):299-306. doi: 10.1046/j.1365-2125.2003.01768.x. Br J Clin Pharmacol. 2003. PMID: 12630981 Free PMC article.

5

Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.

Corvol JC, Bouzamondo A, Sirol M, Hulot JS, Sanchez P, Lechat P. Corvol JC, et al. Among authors: hulot js. Arch Intern Med. 2003 Mar 24;163(6):669-76. doi: 10.1001/archinte.163.6.669. Arch Intern Med. 2003. PMID: 12639199 Review.

6

[Antilipemics and prevention of cerebrovascular accidents. Meta-analysis].

Corvol JC, Bouzamondo A, Sirol M, Hulot JS, Sanchez P, Lechat P. Corvol JC, et al. Among authors: hulot js. Therapie. 2003 Jan-Feb;58(1):37-48. doi: 10.2515/therapie:2003006. Therapie. 2003. PMID: 12822199 French.

7

Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.

Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M. Isnard R, et al. Among authors: hulot js. Am Heart J. 2003 Oct;146(4):729-35. doi: 10.1016/S0002-8703(03)00365-X. Am Heart J. 2003. PMID: 14564330

8

Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects.

Damy T, Pousset F, Caplain H, Hulot JS, Lechat P. Damy T, et al. Among authors: hulot js. Fundam Clin Pharmacol. 2004 Feb;18(1):113-23. doi: 10.1046/j.1472-8206.2003.00216.x. Fundam Clin Pharmacol. 2004. PMID: 14748763 Clinical Trial.

9

Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustment.

Hulot JS, Vantelon C, Urien S, Bouzamondo A, Mahé I, Ankri A, Montalescot G, Lechat P. Hulot JS, et al. Ther Drug Monit. 2004 Jun;26(3):305-10. doi: 10.1097/00007691-200406000-00015. Ther Drug Monit. 2004. PMID: 15167633 Clinical Trial.

10

Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure.

Gackowski A, Isnard R, Golmard JL, Pousset F, Carayon A, Montalescot G, Hulot JS, Thomas D, Piwowarska W, Komajda M. Gackowski A, et al. Among authors: hulot js. Eur Heart J. 2004 Oct;25(20):1788-96. doi: 10.1016/j.ehj.2004.07.038. Eur Heart J. 2004. PMID: 15474693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters